Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / JAZZ - Avadel Pharmaceuticals' Promising FT218 Trial Offsets Decline In Its Legacy Business


JAZZ - Avadel Pharmaceuticals' Promising FT218 Trial Offsets Decline In Its Legacy Business

Introduction

Avadel Pharmaceuticals (AVDL) was once a niche-drug player which pursued re-certification of products marketed before the FDA required drugs to demonstrate safety for approval in 1938. Prior to this time, adulterated or mislabeled drugs were prohibited from sale by the FDA, but the organization did not require that drugs be approved by it before commercialization. In 2006, the administrative body decided to create an incentive for pharmaceutical companies to establish both efficacy and safety in drugs operating under such regulatory loophole in exchange for granting these products marketing exclusivity until the approval

Read more ...

Stock Information

Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ
Website: jazzpharmaceuticals.com

Menu

JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...